The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Milestones in Parkinson's disease—Clinical and pathologic features
Abstract
The identification of the widespread deposition of fibrillized α‐synuclein in Lewy bodies and Lewy neurites in the brains of patients with Parkinson's disease in 1997 has had a profound impact on how the disease is now conceptualized. The previous focus on the loss of the dopaminergic nigrostriatal system, the concept of subcortical dementia, and the idea that Parkinson's disease was dominated by motor impairment have all given way to research assessing more diverse brain regions, clinical symptoms, and phenotypes. It is now recognized that Parkinson's disease is more than just a loss of midbrain dopaminergic neurons in association with Lewy bodies. There are now several theories on how the disease develops and progresses currently being validated in a variety of studies, although many of these theories have yet to incorporate the phenotypic clinical and pathological changes associated with age. A particularly exciting new area of research involves the cell‐to‐cell transmission of pathogenic proteins. The recent consensus definition of Parkinson's disease dementia will allow its pathologic substrates to be determined. These advances have progressed to a stage where the preclinical stages of Parkinson's disease and its specific signs and symptoms are being predicted and tested clinically. Such strategies herald a future wave of preventive strategies for Parkinson's disease and its clinical symptoms. © 2011 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationMcKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationNeuropathological assessment of Parkinson’s disease: refining the diagnostic criteria
Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972
Self-citationthe Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698
Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., & Ikuta, F. (1988) · Acta Neuropathologica · doi:10.1007/bf00687767 · Cited by 528
Hypocretin (orexin) loss in Parkinson's disease
Fronczek, R., Overeem, S., Lee, S. Y. Y., Hegeman, I. M., van Pelt, J., van Duinen, S. G., Lammers, G. J., & Swaab, D. F. (2007) · Brain · doi:10.1093/brain/awm090 · Cited by 463
Lebouvier, T., Neunlist, M., Bruley des Varannes, S., Coron, E., Drouard, A., N'Guyen, J.-M., Chaumette, T., Tasselli, M., Paillusson, S., Flamand, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012728 · Cited by 427
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
Ballard, C., Ziabreva, I., Perry, R., Larsen, J. P., O'Brien, J., McKeith, I., Perry, E., & Aarsland, D. (2006) · Neurology · doi:10.1212/01.wnl.0000249130.63615.cc · Cited by 335
Lewy Body Pathology in Normal Elderly Subjects
Markesbery, W. R., Jicha, G. A., Liu, H., & Schmitt, F. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ac10a7 · Cited by 210
Lewy Body Pathology in Alzheimer's Disease
Kotzbauer, P. T., Tojanowski, J. Q., & Lee, V. M. V. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:225 · Cited by 177
The effect of age of onset of PD on risk of dementia
Aarsland, D., Kvaløy, J. T., Andersen, K., Larsen, J. P., Tang, M. X., Lolk, A., Kragh-Sørensen, P., & Marder, K. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0234-8 · Cited by 162
Incidental Lewy body disease: Clinical comparison to a control cohort
Adler, C. H., Connor, D. J., Hentz, J. G., Sabbagh, M. N., Caviness, J. N., Shill, H. A., Noble, B., & Beach, T. G. (2010) · Movement Disorders · doi:10.1002/mds.22971 · Cited by 143
Reduced striatal tyrosine hydroxylase in incidental Lewy body disease
Beach, T. G., Adler, C. H., Sue, L. I., Peirce, J. B., Bachalakuri, J., Dalsing-Hernandez, J. E., Lue, L. F., Caviness, J. N., Connor, D. J., Sabbagh, M. N., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0313-7 · Cited by 128
Research works printed but not linked: 72
- Parkinson J, 1817, Essay on the Shaking Palsy
- 10.1002/mds.870040514 · DOI · Paper page
- 10.1001/archneur.1984.04050190080019 · DOI · Paper page
- Kosaka K, 1988, Lewy body disease with and without dementia: a clinicopathological study of 35 cases, Clin Neuropathol, 7, 299
- Braak H, 1995, Nigral and extranigral pathology in Parkinson's disease, J Neural Transm Suppl, 46, 15
- Double KL, 1996, Regional brain atrophy in idiopathic Parkinson's disease and diffuse Lewy body disease, Dementia, 7, 304
- 10.1002/mds.22867 · DOI
- 10.1093/brain/114.5.2283 · DOI · Paper page
- 10.1002/mds.10258 · DOI
- 10.1002/1531-8249(200003)47:3<345::AID-ANA10>3.0.CO;2-V · doi:10.1002/1531-8249(200003)47:3<345::aid-ana10>3.0.co;2-v
- 10.1006/exnr.1997.6418 · DOI
- Bohnen NI, 2010, The cholinergic system and Parkinson disease, Behav Brain Res
- 10.1093/brain/awm097 · DOI · Paper page
- 10.1002/ana.410270405 · DOI · Paper page
- 10.1093/brain/awf251 · DOI · Paper page
- 10.1002/mds.23305 · DOI
- 10.1093/brain/118.1.131 · DOI
- 10.1002/mds.20289 · DOI
- 10.1016/S0166-2236(03)00038-9 · DOI · Paper page
- 10.1002/mds.21065 · DOI · Paper page
- Wakabayashi K, 1993, [Incidental occurrence of Lewy bodies in the brains of elderly patients—the relevance to aging and Parkinson's disease], No To Shinkei, 45, 1033
- 10.1212/WNL.52.6.1269 · DOI · Paper page
- 10.1111/j.1468-1331.2008.02056.x · DOI · Paper page
- 10.1002/mds.22672 · DOI · Paper page
- 10.1038/nrn2477 · DOI · Paper page
- 10.1007/s00401-008-0344-8 · DOI · Paper page
- 10.1007/s00401-008-0345-7 · DOI · Paper page
- 10.1002/mds.22637 · DOI
- 10.1111/j.1365-2990.2007.00923.x · DOI · Paper page
- 10.1111/j.1365-2990.2008.00937.x · DOI
- 10.1111/j.1749-6632.2009.05118.x · DOI · Paper page
- 10.1002/ana.21541 · DOI · Paper page
- 10.1111/j.1750-3639.2007.00117.x · DOI
- 10.1016/0021-9681(75)90058-2 · DOI · Paper page
- 10.1002/mds.870100309 · DOI · Paper page
- 10.1159/000109757 · DOI
- 10.1288/00005537-198402000-00004 · DOI · Paper page
- 10.1212/WNL.38.8.1237 · DOI · Paper page
- 10.1212/WNL.43.5.962 · DOI
- 10.1093/jnen/61.5.413 · DOI · Paper page
- 10.1002/mds.21560 · DOI · Paper page
- 10.1007/BF02292766 · DOI
- 10.1093/brain/awm302 · DOI · Paper page
- 10.1002/mds.21989 · DOI · Paper page
- 10.1111/j.1440-1827.2004.01680.x · DOI
- 10.1111/j.1750-3639.2006.00032.x · DOI · Paper page
- 10.1002/mds.23348 · DOI
- 10.1002/mds.23347 · DOI
- 10.1002/mds.22757 · DOI
- 10.1212/WNL.0b013e3181ca0166 · DOI · Paper page
- 10.1212/WNL.45.4.709 · DOI · Paper page
- 10.1212/WNL.55.11.1730 · DOI
- 10.1093/brain/awm056 · DOI · Paper page
- 10.1093/brain/awm142 · DOI · Paper page
- 10.1093/brain/awq059 · DOI · Paper page
- 10.1093/jnen/62.4.363 · DOI
- 10.1093/jnen/64.2.156 · DOI · Paper page
- 10.1212/01.wnl.0000306697.48738.b6 · DOI · Paper page
- 10.1001/archneur.63.4.584 · DOI · Paper page
- 10.1212/01.WNL.0000065889.42856.F2 · DOI · Paper page
- 10.1212/01.wnl.0000266626.64913.0f · DOI
- 10.1111/j.1750-3639.2000.tb00269.x · DOI · Paper page
- 10.1212/01.WNL.0000158422.41380.82 · DOI · Paper page
- 10.1212/WNL.43.9.1690 · DOI
- 10.1212/WNL.54.8.1596 · DOI · Paper page
- 10.1016/j.jns.2009.08.034 · DOI · Paper page
- Jellinger KA, 2000, Morphological substrates of mental dysfunction in Lewy body disease: an update, J Neural Transm Suppl, 59, 185
- 10.1007/s00401-009-0597-x · DOI
- 10.1111/j.1750-3639.2009.00371.x · DOI
- Harding AJ, 2001, Cortical Lewy body pathology in the diagnosis of dementia, Acta Neuropathol (Berl), 102, 355, 10.1007/s004010100390 · DOI · Paper page
- 10.1001/archneur.59.1.102 · DOI · Paper page
- 10.1002/mds.22719 · DOI
Cited by
Olfactory dysfunction in Parkinson disease
Doty, R. L. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.80 · Cited by 737
Mhyre, T. R., Boyd, J. T., Hamill, R. W., & Maguire-Zeiss, K. A. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-5416-4_16 · Cited by 423
Baltazar, M. T., Dinis-Oliveira, R. J., de Lourdes Bastos, M., Tsatsakis, A. M., Duarte, J. A., & Carvalho, F. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.039 · Cited by 410
Review: Sporadic Parkinson's disease: development and distribution of α‐synuclein pathology
Del Tredici, K., & Braak, H. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12298 · Cited by 398
Non motor subtypes and Parkinson's disease
Sauerbier, A., Jenner, P., Todorova, A., & Chaudhuri, K. R. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.027 · Cited by 375
Metadata
- Authors
- Halliday, G., Lees, A., & Stern, M.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2011-05
- Volume
- 26
- Issue
- 6
- Pages
- 1015-1021
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2129848302
- Cited by
- 196
- References
- 15
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.